[HTML][HTML] Poly (ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy

W Qin, G Liu, J Wang, H Wang, J Zhang, F Zhang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Diabetic cardiomyopathy (DCM) is characterized by structural alterations such as
cardiomyocyte hypertrophy, necrosis and focal fibrosis. Poly (ADP-ribose) polymerase 1 …

PARP mediates structural alterations in diabetic cardiomyopathy

J Chiu, H Farhangkhoee, BY Xu, S Chen… - Journal of molecular and …, 2008 - Elsevier
Diabetic cardiomyopathy is characterized by structural alterations such as cardiomyocyte
hypertrophy, necrosis and focal fibrosis. Hyperglycemia-induced oxidative damage may play …

PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis

M Waldman, V Nudelman, A Shainberg… - Experimental cell …, 2018 - Elsevier
Abstract Type 2 diabetes mellitus (DM2) follows impaired glucose tolerance in obesity and is
frequently associated with hypertension, causing adverse myocardial remodelling and …

Poly (ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing …

CY Xiao, M Chen, Z Zsengeller, C Szabo - Journal of Pharmacology and …, 2004 - ASPET
Activation of the nuclear enzyme poly (ADP-ribose) polymerase (PARP)-1 by oxidant-
mediated DNA damage is an important pathway of cell dysfunction and tissue injury during …

Increased expression of poly (ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure

JB Pillai, HM Russell, J Raman… - American Journal …, 2005 - journals.physiology.org
Poly (ADP-ribose) polymerase-1 (PARP-1) plays a pivotal role in regulating genome
stability, cell cycle progression, and cell survival. However, overactivation of PARP has been …

AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy

M Liu, Z Li, GW Chen, ZM Li, LP Wang, JT Ye… - Molecular and Cellular …, 2014 - Elsevier
Abstract Poly (ADP-ribose) polymerase-1 (PARP-1) enzyme, as a sensor of DNA damage,
could convert nicotinamide adenine dinucleotide (NAD) into long poly (ADP-ribose) chains …

Poly (ADP-ribose) polymerase 1 inhibition improves coronary arteriole function in type 2 diabetes mellitus

SK Choi, M Galán, M Kassan, M Partyka, M Trebak… - …, 2012 - Am Heart Assoc
Type 2 diabetes mellitus (T2DM) is associated with microvascular dysfunction. We
hypothesized that increased poly (ADP-ribose) polymerase 1 (PARP-1) activity contributes …

Activation of the poly (ADP-ribose) polymerase pathway in human heart failure

A Molnár, A Tóth, Z Bagi, Z Papp, I Édes, M Vaszily… - Molecular …, 2006 - Springer
Abstract Poly (ADP-ribose) polymerase (PARP) activation has been implicated in the
pathogenesis of acute and chronic myocardial dysfunction and heart failure. The goal of the …

Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly (ADP-ribose) polymerase-1

M Chen, Z Zsengellér, CY Xiao… - Cardiovascular …, 2004 - academic.oup.com
Objective: Oxidant stress-induced activation of poly (ADP-ribose) polymerase (PARP) plays
a role in the pathogenesis of various cardiovascular diseases. We have now investigated …

PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals

EM Zakaria, HM El-Bassossy, NN El-Maraghy… - European journal of …, 2016 - Elsevier
Cardiovascular complications are the major causes of mortality among diabetic population.
Poly (ADP-ribose) polymerase-1 enzyme (PARP-1) is activated by oxidative stress leading …